Gene · 3093
Papers3,161
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,161
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interplay of NEAT1 and miR-339-5p Influences on Mesangial Gene Expression and Function in Various Diabetic-Associated Injury Models. | Noncoding RNA | 2022 | 35893235 | PubTator, text mining | PubMed |
| Overview of Transcriptomic Research on Type 2 Diabetes: Challenges and Perspectives. | Genes (Basel) | 2022 | 35885959 | PubTator, text mining | PubMed |
| Identification and Validation of Novel Potential Pathogenesis and Biomarkers to Predict the Neurological Outcome after Cardiac Arrest. | Brain Sci | 2022 | 35884735 | PubTator, text mining | PubMed |
| Behavioral manifestations in rodent models of autism spectrum disorder: protocol for a systematic review and network meta-analysis. | Syst Rev | 2022 | 35883206 | PubTator, text mining | PubMed |
| Using AI-Based Evolutionary Algorithms to Elucidate Adult Brain Tumor (Glioma) Etiology Associated with IDH1 for Therapeutic Target Identification. | Curr Issues Mol Biol | 2022 | 35877430 | PubTator, text mining | PubMed |
| Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis. | Front Cell Dev Biol | 2022 | 35874839 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system in diabetic retinopathy. | PeerJ | 2022 | 35873915 | PubTator, text mining | PubMed |
| Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma. | Med Sci Monit | 2022 | 35871777 | PubTator, text mining | PubMed |
Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network. | Oxid Med Cell Longev | 2022 | 35864871 | PubTator, text mining | PubMed |
| Immunotherapy landscape analyses of necroptosis characteristics for breast cancer patients. | J Transl Med | 2022 | 35864548 | PubTator, text mining | PubMed |
| Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 Interfaces. | Antimicrob Agents Chemother | 2022 | 35861550 | PubTator, text mining | PubMed |
| PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication. | J Virol | 2022 | 35861516 | PubTator, text mining | PubMed |
| PSMC1 variant causes a novel neurological syndrome. | Clin Genet | 2022 | 35861243 | PubTator, text mining | PubMed |
| High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients. | Dis Markers | 2022 | 35855850 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Uncovers Specific Genetic Variation Difference Based on Different Modes of Drug Resistance in Small Cell Lung Cancer. | Front Oncol | 2022 | 35847960 | PubTator, text mining | PubMed |
| Network pharmacology-based analysis of the effects of puerarin on sarcopenia. | Ann Transl Med | 2022 | 35845507 | PubTator, text mining | PubMed |
| RNA-seq reveals co-dysregulated circular RNAs in the adenomyosis eutopic endometrium and endometrial-myometrial interface. | BMC Womens Health | 2022 | 35841021 | PubTator, text mining | PubMed |
| Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway. | Mol Cancer | 2022 | 35840930 | PubTator, text mining | PubMed |
| Time Course Analysis of Transcriptome in Human Myometrium Depending on Labor Duration and Correlating With Postpartum Blood Loss. | Front Genet | 2022 | 35836580 | PubTator, text mining | PubMed |
| Exosomal miRNA Expression Profiling and the Roles of Exosomal miR-4741, miR-32, miR-3149, and miR-6727 on Gastric Cancer Progression. | Biomed Res Int | 2022 | 35832845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3093/papers?page=34